News
Here are the key takeaways from the full Times Magazine story about the F.D.A.: The F.D.A.’s regulators have an enormous ...
Jeneen Interlandi, a domestic correspondent for Opinion and a staff writer at the magazine, writes frequently about public health. For this article, she interviewed dozens of people who have worked ...
Beyond staff cuts, the departures of some longtime investigators in recent months have left less experienced people tasked ...
FDA Begins Public Comment Period on Method for Ranking Chemicals in Food for Post-Market Assessments
The U.S. Food and Drug Administration (FDA) announced on June 18, 2025, the release of its proposed method for ranking ...
The FDA has approved garadacimab-gxii for prophylactic use in patients aged 12 years and older with hereditary angioedema, ...
Syndax now has two approved therapies, but the share price remains under pressure despite these milestones. See why SNDX ...
Boston Scientific announced the FDA approval of expanded labeling for its pulsed field ablation system which now includes ...
FDA approval of EKTERLY makes KalVista Pharmaceuticals, Inc. the first to offer an oral on-demand HAE therapy. Click here to find out why KALV is a Strong Buy.
From FDA approvals streamlining access to critical therapies to new breakthroughs in challenging malignancies, the field of ...
A top official at the Food and Drug Administration recently overruled government scientists on the availability of two COVID-19 vaccines. Newly released documents show the FDA’s vaccine chief, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results